Companies · Other Health Care

Patientsafe Solutions, Inc.

SAN DIEGO · Other Health Care

Diligence memoA one-page analyst read on Patientsafe Solutions, Inc. — recommendation, valuation, rhythm, risks.
$76.7M
Total raised · real
7
Rounds
3.4×
Latest step-up
Top 6%
Sector rank · raised
Series B
Latest stage · inferred · Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Patientsafe Solutions, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.74× the median modeled value of Series B Other Health Care companies in 2016–2018 (74 peers) — value vs value, same stage and era.
  • Within the normal band (74% of peer median) for its niche.
Dormant
  • Last raise 8.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Patientsafe Solutions, Inc. is one of 5377 Other Health Care companies tracked from SAN DIEGO. By capital raised it ranks among the largest (ahead of 95% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2017-09-12
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2009-04-01 Raised $6.4M (real) Modeled valuation $129M (est)Series A2009Seed · 2009-04-01 Raised $2.0M (real) Modeled valuation $50M (est)Seed2009Series B · 2009-04-01 Raised $24M (real) Modeled valuation $528M (est)Series B2009Series B · 2012-06-07 Raised $5.5M (real) Modeled valuation $121M (est)Series B2012Series B · 2012-12-07 Raised $13M (real) Modeled valuation $294M (est)Series B2012Series B · 2013-09-10 Raised $12M (real) Modeled valuation $259M (est)Series B2013Series B · 2013-12-18 Raised $3.0M (real) Modeled valuation $66M (est)Series B2013Series B · 2016-08-03 Raised $4.5M (real) Modeled valuation $99M (est)Series B2016Series B · 2017-09-12 Raised $15M (real) Modeled valuation $332M (est)Series B2017+$2.0M+$24M+$5.5M+$13M+$12M+$3.0M+$4.5M+$15MCumulative $85M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.4M · 2009
Bridge · Series A-stage$2.0M · 2009smaller follow-on
Series B$23.8M · 2009
Series B extension$5.5M · 2012
Series B extension$13.3M · 2012
Series B extension$11.7M · 2013
Series B extension$3.0M · 2013
Series B extension$4.5M · 2016
Series B extension$15.0M · 2017

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$332.3M
Base estimate est.
$35.2M
Conservative case
$1.3B
Upside case
$83.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $129.2M · 2009-04-012009Seed · modeled $49.6M · 2009-04-01Series B · modeled $527.8M · 2009-04-01Series B · modeled $120.9M · 2012-06-07Series B · modeled $294.2M · 2012-12-07Series B · modeled $258.6M · 2013-09-10Series B · modeled $66.5M · 2013-12-18Series B · modeled $99.0M · 2016-08-03Series B · modeled $332.3M · 2017-09-122017
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
8.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
13 mo
Avg between rounds
$9.1M/yr
Capital velocity
17.3 yr
On record since
2009
First round
9
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 32× above median
This company$76.7M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.8× of median
This company$15.0M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 15× above median
This company$332.3M
Sector median$22.1M

Raised more than 95% of sector peers (real $). Modeled value above 91% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #53 of 74.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Podicare Services, Inc. · Series B Raised $40.0M · modeled $886.2M (est)COTA, Inc. · Series B Raised $43.8M · modeled $886.2M (est)Fresenius Medical Care - Meridian Health System, LLC · Series B Raised $39.0M · modeled $863.9M (est)Headspace, Inc. · Series B Raised $115.9M · modeled $860.6M (est)Spine Holdings LLC · Series B Raised $38.4M · modeled $851.6M (est)Chrono Therapeutics Inc. · Series B Raised $51.4M · modeled $833.2M (est)MedCPU, Inc. · Series B Raised $36.6M · modeled $776.2M (est)Capital Funding Bancorp, Inc. · Series B Raised $35.0M · modeled $775.4M (est)Phreesia, Inc. · Series B Raised $83.8M · modeled $753.2M (est)Labconnect Holdings, Inc. · Series B Raised $33.4M · modeled $739.0M (est)Zoonie, LLC · Series B Raised $52.0M · modeled $708.1M (est)Sotera Wireless, Inc. · Series B Raised $98.5M · modeled $705.3M (est)Patientsafe Solutions, Inc. (this company) Raised $76.7M · modeled $332.3M (est)Patientsafe Solutions, Inc.
CompanyStageRaised · realValue · estvs peer med.
Podicare Services, Inc.Series B$40.0M$886.2M1.98×
COTA, Inc.Series B$43.8M$886.2M1.98×
Fresenius Medical Care - Meridian Health System, LLCSeries B$39.0M$863.9M1.93×
Headspace, Inc.Series B$115.9M$860.6M1.92×
Spine Holdings LLCSeries B$38.4M$851.6M1.90×
Chrono Therapeutics Inc.Series B$51.4M$833.2M1.86×
MedCPU, Inc.Series B$36.6M$776.2M1.73×
Capital Funding Bancorp, Inc.Series B$35.0M$775.4M1.73×
Phreesia, Inc.Series B$83.8M$753.2M1.68×
Labconnect Holdings, Inc.Series B$33.4M$739.0M1.65×
Zoonie, LLCSeries B$52.0M$708.1M1.58×
Sotera Wireless, Inc.Series B$98.5M$705.3M1.58×
Patientsafe Solutions, Inc. this companySeries B$76.7M$332.3M0.74×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.4M2009-04-01$29.1M$129.2M85%
Seed$2.0M2009-04-01$10.0M$49.6M85%
Series B$23.8M2009-04-01$132.4M$527.8M85%
Series B$5.5M2012-06-07$30.3M$120.9M85%
Series B$13.3M2012-12-07$73.8M$294.2M85%
Series B$11.7M2013-09-10$64.8M$258.6M85%
Series B$3.0M2013-12-18$16.7M$66.5M85%
Series B$4.5M2016-08-03$24.8M$99.0M85%
Series B$15.0M2017-09-12$83.3M$332.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.4M2009-04-01
    • First recorded raise — entered as Series A.
    • 34 investors on this round.
  2. Seed$2.0M2009-04-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.2× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  3. Series B$23.8M2009-04-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 11.9× larger than the prior — scaling up.
    • 34 investors on this round.
  4. Series B$5.5M2012-06-07
    • Raised again after 38 mo — slower than the ~14 mo sector norm.
    • Round 4.4× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  5. Series B$13.3M2012-12-07
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
    • 33 investors on this round.
  6. Series B$11.7M2013-09-10
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 06).
    • 19 investors on this round.
  7. Series B$3.0M2013-12-18
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 3.9× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  8. Series B$4.5M2016-08-03
    • Raised again after 32 mo — slower than the ~14 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 7 investors on this round.
  9. Series B$15.0M2017-09-12
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 3.4× larger than the prior — scaling up.
    • 1 investor on this round.
Intelligence
2018 ~Q4
Modeled next raise · ~13mo cadence
$45.0M
Modeled next size est.range $29.2M$72.0M
3.4×
Last step-up
$9.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Kim22 other2017-09
PAUL SEKHRI6 other2012-06
LISA SUENNEN4 other2009-04
Doug Carlisle3 other2009-04
Joel Krikston3 other2016-08
DICK ALLEN2 other2009-04
James Sweeney2 other2009-04
CHRISTOPHER KERSEY1 other2012-06
CHRISTOPHER M. KERSEY1 other2009-04
JOHN KUNHART1 other2009-04
Lawrence Low1 other2016-08
Loren Tarmo1 other2017-09
Paul A. Sekhri1 other2012-12
Stephen Krupa1 other2016-08
STEPHEN M. KRUPA1 other2009-04
Bruce A. Eklund2013-09
Cayce Denton2016-08
CHAD J. PUTNAM2009-04
Chris Stokes2017-09
Christopher A. Kersey2012-12
Christopher Kitching2017-09
DAVID D. SWENSON2009-04
Frank A. Pecaitis2013-09
GREGG M. IMAMOTO2009-04
Registry & provenance

Patientsafe Solutions, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1274375
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
MedCPU, Inc.Other Health CareSeries B$36.6M$776.2Mnetwork1 shared operator · same sector · same stage
Aseko Inc.Other Health CareSeries B$75.9M$211.4Msame sector · same stage
iWalk, Inc.Other Health CareSeries B$74.5M$377.9Msame sector · same stage
Pathology Holdings, Inc.Other Health CareSeries B$79.1M$459.1Msame sector · same stage
Auxogyn IncOther Health CareSeries B$73.1M$327.3Msame sector · same stage
Genomedx Inc.Other Health CareSeries B$72.9M$176.3Msame sector · same stage
Esperion Therapeutics, Inc.Other Health CareSeries B$72.7M$376.6Msame sector · same stage
MacuLogix, Inc.Other Health CareSeries B$82.1M$163.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Patientpay, Inc.Other Health CareSeries A$163.6M89%
PatientPing, Inc.Other Health CareSeries B$701.2M86%
PatientsVoices, LLCOther Health CarePre-Seed$4.6M85%
Myocardial Solutions, Inc.Other Health CareSeries A$18.7M85%
Avive Solutions, Inc.Other Health CareSeries C$515.7M84%
Senior Solutions, LLCOther Health CarePre-Seed$1.2M84%
MindCare Solutions Group, Inc.Other Health CareSeries B$55.4M84%
Preventice Solutions, Inc.Other Health CareSeries D+$1.0B84%
Frequently asked
How much funding has Patientsafe Solutions, Inc. raised?
Patientsafe Solutions, Inc. has raised approximately $76.7M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Patientsafe Solutions, Inc.'s estimated valuation?
Provath's modeled valuation for Patientsafe Solutions, Inc. is approximately $332.3M (modeled range $35.2M–$1.3B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Patientsafe Solutions, Inc. at?
Patientsafe Solutions, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Tue Sep 12.
What does Patientsafe Solutions, Inc. do and where is it based?
Patientsafe Solutions, Inc. operates in the Other Health Care sector, based in SAN DIEGO.
Explore related

See where Patientsafe Solutions, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Patientsafe Solutions, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.